scholarly journals Oropharyngeal adenocarcinoma as a rare presentaton secondary to gastric adenocarcinoma: a case study

2020 ◽  
Vol 6 (12) ◽  
pp. 2316
Author(s):  
Rajeev Kumar Jain ◽  
Deepak Kumar Gupta ◽  
Chultim Dolma Bhutia ◽  
Ashvanee Kumar Chaudhary ◽  
Vishwambhar Singh ◽  
...  
Keyword(s):  
Adjuvant Chemotherapy ◽  
Gastric Adenocarcinoma ◽  
Successful Treatment ◽  
Primary Site ◽  
Distant Site ◽  
Base Of Tongue

<p class="abstract">Adenocarcinoma of oropharynx is a rarely encountered entity. It may be primary or secondary as metastasis from a distant site. Secondary adenocarcinoma of base of tongue is even more uncommon, few cases have been reported in the literature till date including one from stomach as a primary site. We are presenting a case of secondary adenocarcinoma of base of tongue metastasised from stomach after one and half years of successful treatment consisting of surgery and adjuvant chemotherapy.</p>

scholarly journals Hamartomatous lesion at the base of tongue: A rare entity

2021 ◽  
Vol 6 (3) ◽  
pp. 223-225
Author(s):  
Neelam Gupta ◽  
Ankush Blaggan ◽  
Vikas Dubey ◽  
Mehak Kashyap ◽  
Nechal Kaur
Keyword(s):  
Histopathological Examination ◽  
Rare Entity ◽  
Base Of Tongue ◽  
Base Of The Tongue

Hamartomas are benign proliferative lesions with no metastatic properties. The hamartoma of the tongue is usually rare. It is usually difficult to diagnose grossly. But can be diagnosed definitely with help of histopathological examination. Our case study is on a 5-year-old female who was asymptomatic and presented with cystic swelling at the base of the tongue which was initially diagnosed as a cyst but was diagnosed histopathologically as a hamartoma.

scholarly journals Successful Treatment with the Chin-down Maneuver of Dysphagia Secondary to Descending Necrotizing Mediastinitis: A Case Study

2020 ◽  
Vol 5 (0) ◽  
pp. n/a
Author(s):  
Yuji Koyama ◽  
Yuri Isaji ◽  
Ayaka Sugimoto ◽  
Michi Tochikura ◽  
Takashi Kasahara ◽  
...  
Keyword(s):  
Successful Treatment ◽  
Descending Necrotizing Mediastinitis ◽  
Chin Down

CBT for a Person With Schizophrenia: Systematic Desensitization for Phobias Led to Positive Symptom Improvement

2005 ◽  
Vol 33 (2) ◽  
pp. 249-254 ◽  
Author(s):  
Robert Dudley ◽  
Jaime Dixon ◽  
Douglas Turkington
Keyword(s):  
Successful Treatment ◽  
Specific Phobia ◽  
Positive Symptom ◽  
Psychotic Symptoms ◽  
Symptom Improvement ◽  
Systematic Desensitization ◽  
Antipsychotic Medications ◽  
Affective Symptoms ◽  
Effect Of Treatment

Affective symptoms are often present and under-treated in schizophrenia. This case study reports the effect of treatment of a specific phobia and associated avoidance on the psychotic symptoms of a patient with medication resistant schizophrenia. The treatment of the specific phobia and agoraphobia followed a traditional systematic desensitization procedure. The successful treatment of the phobias led to improvements in psychotic symptoms. Previously, the client had only a limited response to a number of antipsychotic medications including clozapine but responded well to a traditional systematic desensitization program that produced positive consequences for the psychotic symptomatology. The clinical and theoretical aspects of this case are discussed.

Adjuvant chemotherapy following surgical resection for small-cell carcinoma of the lung.

1988 ◽  
Vol 6 (5) ◽  
pp. 832-838 ◽  
Author(s):  
F A Shepherd ◽  
W K Evans ◽  
R Feld ◽  
V Young ◽  
G A Patterson ◽  
...  
Keyword(s):  
Adjuvant Chemotherapy ◽  
Median Survival ◽  
Cranial Irradiation ◽  
Primary Treatment ◽  
Small Cell ◽  
Primary Site ◽  
Resection Margins ◽  
Nodal Involvement ◽  
Term Survival ◽  
Number Of Patients

Surgery alone is inadequate therapy for limited small-cell lung cancer (SCLC), resulting in less than 5% long-term survival. Since 1976, we treated patients undergoing surgery for SCLC with adjuvant chemotherapy in an attempt to prolong survival and increase cure. Seventy-seven patients who underwent surgery as their primary treatment were identified, and of these 63 (46 male and 17 female) received chemotherapy. Fifteen patients had a pneumonectomy, 46 a lobectomy, and two had wedge resections. Six patients had positive microscopic resection margins. Pathologic staging showed tumor, node, metastasis (TNM) involvement as follows: T1N0, eight; T2N0, ten; T1N1, six; T2N1, 18; T1N2, five; T2N2, nine; T3N0, three; T3N1, one; and T3N2, three. All patients received cyclophosphamide, Adriamycin (doxorubicion; Adria Laboratories, Mississauga, Ontario), and vincristine; four also received etoposide (VP-16) and cisplatin, one VP-16, and four methotrexate, procarbazine, and lomustine (CCNU). Forty-nine patients received prophylactic cranial irradiation, and 35 received radiotherapy to the mediastinum and primary site. The overall median survival of the 63 patients is 83 weeks, and the projected 5-year survival is 31%. Patients with T1 or T2 tumors without nodal involvement had a median survival of 191 weeks, and projected 5-year survival of 48%. Stage II (T1N1, T2N1) and stage III (any T3 or T1-2N2) patients had median survivals of 72 weeks and 65 weeks, and projected 5-year survivals of 24.5% and 24%, respectively. Thirty-three patients have relapsed and died of disease. Only two patients had an isolated relapse at the primary site. Seven other patients have died without recurrent disease. Adjuvant chemotherapy after surgery results in prolonged survival and cure for a significant number of patients with stage I SCLC, although nodal involvement at any level is associated with shorter survival.

Successful Treatment of Bilateral Diffuse Uveal Melanocytic Proliferation With Plasmapheresis

2017 ◽  
Vol 1 (6) ◽  
pp. 420-423
Author(s):  
Matthew S. J. Katz ◽  
Henry Alexander Leder ◽  
Tahsin Choudhury
Keyword(s):  
Successful Treatment ◽  
Small Cell Lung Carcinoma ◽  
Care Center ◽  
Tertiary Care ◽  
Great Promise ◽  
Visual Response ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma ◽  
Paraneoplastic Disorder

Introduction: Bilateral diffuse uveal melanocytic proliferation (BDUMP) is a rare paraneoplastic disorder that bears grave ocular prognosis. No consensus exists regarding treatment regimen and very little has been achieved in the way of successful treatment. We present here a case of BDUMP associated with metastatic non–small cell lung carcinoma treated successfully with plasmapheresis. Methods: This is a nonmasked, retrospective interventional case study conducted at a tertiary care center, characterizing bilateral disease in 1 patient, and describing response to plasmapheresis. Outcome measures were resolution of optical coherence tomography (OCT) findings, as well as visual response. Results: Resolution of bilateral exudative retinal detachments was documented with both ophthalmoscopic photography and OCT and accompanied by concurrent improvement in visual function. Conclusion: Bilateral diffuse uveal melanocytic proliferation has been treated with plasmapheresis in only 3 previously reported cases. This case demonstrates and reinforces the great promise in the treatment of this rare and devastating condition.

Sign in / Sign up

Export Citation Format

Share Document